DoD Peer Reviewed Cancer, Career Development Award- Scholar Option
ID: 353919Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353919
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Career Development Award (CDA) to support early-career investigators in conducting impactful cancer research relevant to military health. This grant, with an estimated total program funding of $15.36 million, aims to foster the development of Scholars—early-career researchers—who will work under the mentorship of experienced cancer researchers, referred to as Career Guides, within the framework of the Virtual Cancer Center (VCC). The initiative emphasizes the importance of advancing cancer research that addresses the health concerns of Service Members and their families, with a maximum budget of $800,000 available for each project over a period of up to four years. Interested applicants must submit a pre-application by July 12, 2024, and a full application by July 26, 2024, with further inquiries directed to the CDMRP Help Desk at help@eBRAP.org.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524PRCRPCDASO_GG_Mod.pdf
    The Department of Defense (DOD) is announcing the FY24 Peer Reviewed Cancer Career Development Award (CDA) under the Defense Health Program, with a focus on improving cancer research and addressing military health concerns. This award, with $130 million allocated, aims to support early-career investigators—referred to as Scholars—in conducting impactful cancer research relevant to Service Members and their families. Applications must address specific topic areas, excluding melanoma and certain tumors, and demonstrate relevance to military health. The Scholar’s proposal must be accompanied by a Career Guide, an experienced researcher who commits to mentoring and supporting the Scholar through the Virtual Cancer Center (VCC). Key components of the application include a comprehensive career development plan, research strategy, and annual commitments to the VCC. The maximum budget for each project is set at $800,000 for a period of up to four years. Several submission deadlines are established, including a pre-application due by July 12, 2024, and a full application by July 26, 2024. The application will undergo rigorous peer and programmatic review processes to ensure quality and relevance. The initiative signifies DOD's dedication to advancing cancer research and improving health outcomes for the military community.
    Similar Opportunities
    DoD Rare Cancers, Concept Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering a grant opportunity under the FY25 Rare Cancers Research Program (RCRP) Concept Award, aimed at funding innovative research focused on rare cancers. This program seeks to support groundbreaking, untested studies that can potentially lead to new avenues of investigation in the field, particularly benefiting active-duty service members, veterans, military beneficiaries, and the general public. With an estimated total funding of approximately $2.38 million, individual applications can request up to $140,000, and the performance period for funded projects is capped at two years. Interested applicants must submit a Letter of Intent by July 22, 2025, followed by a full application due by August 26, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Medical Research Program, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity under the Peer Reviewed Medical Research Program (PRMRP) for the fiscal year 2025, specifically for the Clinical Trial Award (CTA). This program aims to support the rapid implementation of clinical trials that can significantly impact the treatment or management of diseases relevant to military health, with a focus on areas such as autoimmune disorders, cardiovascular health, infectious diseases, and neuroscience. Approximately $32 million is available for this initiative, with an expected four awards, each capped at $8 million, and applications are due by July 21, 2025. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    DoD Rare Cancers, Resource and Community Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.
    DoD Melanoma, Melanoma Academy Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY25 Melanoma Academy Scholar Award to support early-career melanoma researchers. This grant aims to foster independent scientists who are within seven years of their initial faculty appointment by integrating them into a virtual collaborative academy that emphasizes mentorship and research development in melanoma. The program is particularly focused on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research, with a total funding allocation of approximately $1.76 million for two awards, each capped at $550,000 over a maximum period of three years. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due on October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Breast Cancer Era of Hope Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program's Era of Hope Scholar Award, aimed at early-career scientists with the potential to innovate in breast cancer research. This grant program, with an estimated total funding of approximately $10.85 million, will support two awards, each capped at $3.5 million for a maximum term of four years. The award emphasizes the importance of innovative research approaches to advance understanding and treatment of breast cancer, requiring Principal Investigators to commit at least 25% of their time to the project and to include two breast cancer consumer advocates in their research teams. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Breast Cancer Breakthrough Award Level 3
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. Applicants are required to address at least one of the Department of Defense-defined challenges related to breast cancer, and the research team must include breast cancer consumer advocates to ensure patient perspectives are integrated into the research process. This grant program allocates approximately $27.9 million for three awards, with funding caps of $4 million for single Principal Investigators and $5 million for projects involving a Partnering PI. Pre-applications are due by June 13, 2025, and full applications must be submitted by September 10, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Survivorship Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Survivorship Research Award to support innovative research aimed at enhancing the health and well-being of melanoma survivors and their caregivers. This grant encourages collaborative research that integrates insights from melanoma consumers, with a focus on various aspects of survivorship, including psychological impacts, symptom management, and healthcare delivery challenges, while explicitly excluding studies limited to animal models or survival rates without quality of life considerations. The total estimated program funding is $2,320,000, with a maximum award amount of $725,000 per project over a three-year performance period. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Melanoma, Melanoma Academy Leadership Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Melanoma Academy Leadership Award, a federal grant aimed at establishing a Director and Deputy Director for the Melanoma Research Program's virtual academy. This initiative seeks to cultivate high-performing melanoma researchers by fostering mentorship and collaboration between established and early-career investigators, with a focus on enhancing patient outcomes and reducing the burden of melanoma. The total estimated funding for this opportunity is approximately $2.1 million, supporting one application with a direct cost cap of $1.3 million over a maximum performance period of four years. Interested applicants must submit a pre-application by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further inquiries.
    DoD Breast Cancer Clinical Research Extension Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Breast Cancer Clinical Research Extension Award as part of the Fiscal Year 2025 Breast Cancer Research Program (BCRP). This grant aims to enhance the impact of breast cancer clinical studies by extending data collection, follow-up, and analysis, specifically addressing challenges such as early trial termination and limited patient follow-up. Approximately $26.35 million is available to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for partnered PIs, requiring the involvement of at least two breast cancer consumer advocates in the research team. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025, with successful proposals notified within six weeks post-review. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.